BINEX Toekomstige groei

Future criteriumcontroles 2/6

BINEX zal naar verwachting zijn omzet verhogen met 28.9% per jaar.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Pharmaceuticals winstgroei	33.3%
Inkomstengroei	28.9%
Toekomstig rendement op eigen vermogen	13.3%
Dekking van analisten	Low
Laatst bijgewerkt	29 Oct 2024

Recente toekomstige groei-updates

Geen updates

Recent updates

BINEX Co., Ltd. (KOSDAQ:053030) May Have Run Too Fast Too Soon With Recent 28% Price Plummet

Nov 18

Does BINEX (KOSDAQ:053030) Have A Healthy Balance Sheet?

Oct 23

Revenues Not Telling The Story For BINEX Co., Ltd. (KOSDAQ:053030) After Shares Rise 25%

Sep 01

Subdued Growth No Barrier To BINEX Co., Ltd. (KOSDAQ:053030) With Shares Advancing 32%

Jul 01

BINEX Co., Ltd.'s (KOSDAQ:053030) 30% Share Price Plunge Could Signal Some Risk

Apr 17

We Think That There Are More Issues For BINEX (KOSDAQ:053030) Than Just Sluggish Earnings

Mar 22

BINEX Co., Ltd.'s (KOSDAQ:053030) Shares Climb 37% But Its Business Is Yet to Catch Up

Feb 26

Does BINEX (KOSDAQ:053030) Have A Healthy Balance Sheet?

Mar 18

If You Had Bought BINEX (KOSDAQ:053030) Stock A Year Ago, You Could Pocket A 253% Gain Today

Jan 28

Are BINEX Co., Ltd.'s (KOSDAQ:053030) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Dec 24

Winst- en omzetgroeiprognoses

KOSDAQ:A053030 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (KRW Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	257,289	N/A	47,000	12,000	2
12/31/2025	185,654	N/A	14,000	N/A	3
12/31/2024	136,616	N/A	-20,000	-24,000	3
6/30/2024	128,302	-18,860	-36,795	-23,114	N/A
3/31/2024	136,335	-12,165	-17,840	-4,322	N/A
12/31/2023	154,825	4,671	-12,377	3,778	N/A
9/30/2023	160,785	2,845	-8,647	11,421	N/A
6/30/2023	168,715	13,451	-290	22,993	N/A
3/31/2023	169,566	17,625	-17,561	13,061	N/A
12/31/2022	156,677	12,445	-19,391	17,062	N/A
9/30/2022	154,969	16,511	-7,056	28,985	N/A
6/30/2022	148,847	16,354	-9,893	21,913	N/A
3/31/2022	137,081	12,565	-3,398	23,448	N/A
12/31/2021	134,399	19,094	8,850	28,630	N/A
9/30/2021	129,474	10,144	-9,356	9,669	N/A
6/30/2021	129,031	9,390	493	16,968	N/A
3/31/2021	134,424	13,278	13,884	25,530	N/A
12/31/2020	132,976	6,412	10,372	19,918	N/A
9/30/2020	131,550	13,970	15,453	18,834	N/A
6/30/2020	129,097	11,463	9,842	17,084	N/A
3/31/2020	127,064	8,735	1,177	10,174	N/A
12/31/2019	125,259	8,504	1,760	10,785	N/A
9/30/2019	122,942	13,092	10,972	19,557	N/A
6/30/2019	119,099	13,565	11,411	16,314	N/A
3/31/2019	111,203	8,878	14,385	17,211	N/A
12/31/2018	104,043	6,337	11,044	13,561	N/A
9/30/2018	91,167	-4,232	2,473	5,127	N/A
6/30/2018	84,136	-9,325	5,539	7,163	N/A
3/31/2018	79,031	-12,419	N/A	3,341	N/A
12/31/2017	78,026	-10,797	N/A	8,136	N/A
6/30/2017	80,782	-7,528	N/A	13,053	N/A
3/31/2017	81,500	-3,065	N/A	10,766	N/A
12/31/2016	80,924	-3,144	N/A	3,799	N/A
9/30/2016	77,576	-12,169	N/A	6,256	N/A
6/30/2016	74,890	-10,196	N/A	-4,899	N/A
3/31/2016	71,804	-9,553	N/A	-5,623	N/A
12/31/2015	66,539	-9,289	N/A	-4,497	N/A
9/30/2014	56,724	-2,357	N/A	21	N/A
6/30/2014	58,746	-3,158	N/A	-4,720	N/A
3/31/2014	59,260	-3,099	N/A	-6,064	N/A
12/31/2013	57,297	-4,069	N/A	-1,848	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van A053030 boven de spaarquote ( 2.7% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van A053030 naar verwachting sneller zal groeien dan de markt KR

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van A053030 naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: De omzet van A053030 ( 28.9% per jaar) zal naar verwachting sneller groeien dan de markt KR ( 9% per jaar).

Hoge groei-inkomsten: De omzet van A053030 ( 28.9% per jaar) zal naar verwachting sneller groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen A053030 zal naar verwachting over 3 jaar laag zijn ( 13.3 %).

BINEX Toekomstige groei

Future criteriumcontroles 2/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

BINEX Co., Ltd. (KOSDAQ:053030) May Have Run Too Fast Too Soon With Recent 28% Price Plummet

New minor risk - Shareholder dilution

Does BINEX (KOSDAQ:053030) Have A Healthy Balance Sheet?

Revenues Not Telling The Story For BINEX Co., Ltd. (KOSDAQ:053030) After Shares Rise 25%

Subdued Growth No Barrier To BINEX Co., Ltd. (KOSDAQ:053030) With Shares Advancing 32%

New major risk - Revenue and earnings growth

BINEX Co., Ltd.'s (KOSDAQ:053030) 30% Share Price Plunge Could Signal Some Risk

We Think That There Are More Issues For BINEX (KOSDAQ:053030) Than Just Sluggish Earnings

Full year 2023 earnings released: EPS: ₩151 (vs ₩402 in FY 2022)

BINEX Co., Ltd.'s (KOSDAQ:053030) Shares Climb 37% But Its Business Is Yet to Catch Up

First quarter 2023 earnings released: EPS: ₩228 (vs ₩61.00 in 1Q 2022)

Investor sentiment improves as stock rises 16%

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Third quarter 2022 earnings released: EPS: ₩170 (vs ₩159 in 3Q 2021)

No independent directors

Investor sentiment improved over the past week

No independent directors

Now 22% undervalued

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Does BINEX (KOSDAQ:053030) Have A Healthy Balance Sheet?

Full year 2020 earnings released: EPS ₩206 (vs ₩273 in FY 2019)

Investor sentiment deteriorated over the past week

New 90-day low: ₩16,250

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: ₩32,900

If You Had Bought BINEX (KOSDAQ:053030) Stock A Year Ago, You Could Pocket A 253% Gain Today

Are BINEX Co., Ltd.'s (KOSDAQ:053030) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Market pulls back on stock over the past week

BINEX Co., Ltd. announced that it has received KRW 50 billion in funding from Kiwoom Securities Co., Ltd., Aju IB Investment Co., Ltd., Kiwoom Private Equity, Inc.

BINEX Co., Ltd. announced that it expects to receive KRW 12 billion in funding from Kiwoom Securities Co., Ltd., Aju IB Investment Co., Ltd., Kiwoom Private Equity, Inc.

New 90-day high - ₩28,750

First half earnings released

New 90-day high - ₩23,650

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven